Pharmacological Estrogen Administration Causes a FSH-Independent Osteo-Anabolic Effect Requiring ER Alpha in Osteoblasts

Postmenopausal osteoporosis is characterized by declining estrogen levels, and estrogen replacement therapy has been proven beneficial for preventing bone loss in affected women. While the physiological functions of estrogen in bone, primarily the inhibition of bone resorption, have been studied ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Seitz, Sebastian, Keller, Johannes, Schilling, Arndt F., Jeschke, Anke, Marshall, Robert P., Stride, Brenda D., Wintermantel, Tim, Beil, Frank T., Amling, Michael, Schütz, Günther, Tuckermann, Jan, Schinke, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507728/
https://www.ncbi.nlm.nih.gov/pubmed/23209701
http://dx.doi.org/10.1371/journal.pone.0050301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507728/
https://www.ncbi.nlm.nih.gov/pubmed/23209701
http://dx.doi.org/10.1371/journal.pone.0050301

Ejemplares similares